FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:610-611 August 19, 1999 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Jorenby, D. E. Related Article by Jorenby, D. E. PubMed Citation

To the Editor: In their trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation (March 4 issue),¹ Jorenby et al. reach three conclusions. Their first conclusion — that bupropion is an effective treatment for nicotine dependence — is warranted, since previous studies have also found bupropion to be effective.² Their second conclusion is that bupropion plus the nicotine patch produces higher rates of abstinence than the nicotine patch alone, and their third is that bupropion alone produces higher rates of abstinence than the nicotine patch alone. These conclusions are based on the one-year point-prevalence rates of abstinence . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lancaster, T., Stead, L., Silagy, C., Sowden, A. (2000). Regular review: Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 321: 355-358 [Full Text]